Timothy Garvey served as principal investigator for the landmark REDEFINE 1 trial published in The New England Journal of Medicine in 2025, which established the GLP1-cagrilintide combination as producing the highest pharmaceutical weight loss observed to date
it may influence growth hormone release during sleep
doi:10.1054/ghir.1999.9998 Compliance Statement This product is intended for laboratory research use only and is not approved for human or veterinary use
Singh S, Bhatia R, Singh A, Singh P, Kaur R, Khare P, Purama RK, Boparai RK, Rishi P, Ambalam P, Bhadada SK, Bishnoi M, Kaur J, Kondepudi KK (2018) Probiotic attributes and prevention of LPS-induced pro-inflammatory stress in RAW264.7 macrophages and human intestinal epithelial cell line (Caco-2) by newly isolated Weissella cibaria strains
Exclusion criteria (ESM Table 2) were applied
CD20 expression is increased on B lymphocytes from HIV-infected individuals J